Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Part of paid clinical trials in Miami, Florida.

Sponsor
Global Coalition for Adaptive Research
Study ID
NCT06816433
Phase
PHASE2
Status
Suspended

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Intervention D SLS-002 — DRUG
    SLS-002 will be administered via intranasal administration (one spray per nostril, per device) at 78 mg two times per week for the first eight weeks and then once a week for the last four weeks.
  • Intervention D Placebo — DRUG
    A matching placebo will be administered via intranasal administration (one spray per nostril, per device) two times per week for the first eight weeks and then once a week for the last four weeks.

Study Details

This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for Post Traumatic Stress Disorder (PTSD) utilizing an adaptive platform trial (APT) design. Intervention D - SLS-002 will assess the safety and efficacy of SLS-002 in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.

Key Dates

First listed
Feb 10, 2025
Start date
May 31, 2028
Status verified
May 2026
Primary completion
May 31, 2029
Completion
Jul 31, 2029

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention D: SLS-002
  • Placebo Comparator: Intervention D: Placebo

Primary Outcome Measure

Absolute change in the Clinician-Administered PTSD Scale-5-Revised (CAPS-5-R) Past Month total score at Week 12 (Final/Early termination Visit). [ Time Frame: 12 Weeks ]

Locations (9)

FacilityCityStateZIPSite coordinators
Homestead Associates in Research, Inc.MiamiFlorida33032-
Advanced Discovery ResearchAtlantaGeorgia30318-
Tripler Army Medical Center (TAMC)Tripler AMCHawaii96859-
Cincinnati Veteran's Affairs Medical CenterFort ThomasKentucky41075-
Walter Reed National Military Medical Center (WRNMC)BethesdaMaryland20889-5632-
Upstate Clinical Research Associates, LLCWilliamsvilleNew York14221-
Wilford Hall Ambulatory Surgical Center (WHASC)San AntonioTexas78236-
Alexander T. Augusta Military Medical Center (ATAMMC):Fort BelvoirVirginia22060-5285-
Madigan Army Medical CenterJoint Base Lewis McChordWashington98433-

Find similar trials in Miami, FL

Related Studies